The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

“Early detection can reduce lung cancer death rates by 20% — that’s significant,” Dr. Gorbatov says. “In some cases when we ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...

Read: AdventHealth continues to recruit and retain RNs. It’s the only FDA-approved fluorescent imaging technology t ...

Zenocutuzumab received accelerated approval from the FDA for the agent to treat non-small cell lung cancer (NSCLC) or ...

Other parts of India were similarly affected: 89 of 252 cities had air capable of causing breathing discomfort, as per the Central ... to cause cancer, and it is the reason why lung cancer is ...

The American Cancer Society says lung cancer accounts for one in five of all cancer deaths, making it the leading cause of cancer deaths in the nation. We learn more about the screening process ...

“Avelumab’s profile, coupled with AU-007 and low-dose, subcutaneous aldesleukin, could potentially offer a new therapeutic option for patients with advanced or metastatic PD-L1+ non-small cell lung ...

Despite the fact that lung cancer remains the leading cause of cancer death nationwide, it's not all bad news — Incidence rates have decreased over the last five years studied, according to a ...

More and more non-smokers, particularly women, are being diagnosed with lung cancer. The increasing prevalence of lung cancer among non-smokers is raising alarms, especially in countries where air ...